UNIGE document Scientific Article
previous document  unige:43352  next document
add to browser collection

Immunotherapy for glioma: from illusion to realistic prospects?

Published in Educational Book. 2014, p. 51-9
Abstract There is now evidence that the rules established for tumor immunology and immunotherapy in general are relevant for brain tumors. Treatment strategies explored have mainly involved vaccines using either tumor cells or components, and vaccines with defined synthetic peptides. This latter approach offers the advantage to select well-characterized antigens with selective or preferential expression on glioma. This is a prerequisite because collateral damage to the brain is not allowed. A second strategy which is reaching clinical trials is T cell therapy using the patients' own lymphocytes engineered to become tumor reactive. Tumor specificity can be conferred by forced expression of either a high-avidity T cell receptor or an antitumor antibody (the latter cells are called chimeric antigen receptors). An advantage of T cell engineering is the possibility to modify the cells to augment cellular activation, in vivo persistence and resistance to the tumor immunosuppressive milieu. A direct targeting of the hostile glioma microenvironment will additionally be required for achieving potent immunotherapy and various trials are assessing this issue. Finally, combining immunotherapy with immune checkpoint inhibitors and chemotherapy must be explored within rigorous clinical trials that favor constant interactions between the bench and bedside. Regarding immunotherapy for glioma patients, what was an unrealistic dream a decade ago is today a credible prospect.
PMID: 24857060
Full text
Article (Published version) (464 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Article (Published version) (464 Kb) - public document Free access
Research groups Immunothérapie des cancers (42)
Immunobiologie des tumeurs du cerveau (669)
(ISO format)
DIETRICH, Pierre-Yves, DUTOIT VALLOTTON, Valérie, WALKER, Paul Richard. Immunotherapy for glioma: from illusion to realistic prospects?. In: Educational Book, 2014, p. 51-9. doi: 10.14694/EdBook_AM.2014.34.51 https://archive-ouverte.unige.ch/unige:43352

839 hits



Deposited on : 2014-12-15

Export document
Format :
Citation style :